We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease

By LabMedica International staff writers
Posted on 14 May 2026

Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. More...

Rapid, on-the-spot testing can shorten turnaround times and reduce travel and costs, but its effect on patient engagement is less clear. Understanding whether immediate results improve self-management is critical for chronic disease care. New findings demonstrate how point-of-care testing can enhance health literacy and patient confidence.

Flinders University (Adelaide, Australia) evaluated point-of-care testing (POCT), pathology assays performed at or near the site of care that generate results during the same visit. Examples include finger-prick blood tests that enable immediate review with a clinician rather than days later via a centralized laboratory. The analysis examined whether POCT influences health literacy, defined as the ability to access, understand, remember, and use health information in daily life.

Published in BMC Public Health, the systematic review assessed 13 studies from multiple countries and included more than 21,000 participants. Most studies focused on non-communicable diseases, particularly diabetes and cardiovascular disease. Outcomes extended beyond clinical endpoints to capture changes in patient understanding of disease, confidence in self-management, motivation for lifestyle modification, and measures such as anxiety and quality of life.

Across cohorts, POCT was associated with better understanding of conditions and increased confidence in self-management, together with greater motivation to improve diet and physical activity. Several studies reported improved medication adherence and favorable shifts in clinical markers, including reductions in long-term blood glucose among people with diabetes. Parents of children with diabetes reported higher confidence when immediate results were available, and community testing initiatives prompted participants to consider healthier choices.

The review was led by Flinders University, including the Flinders Health and Medical Research Institute’s International Center for Point-of-Care Testing. Authors noted that speed and clinical context may shape how patients engage with test results, supporting conversations that connect everyday decisions with long-term outcomes. They also called for research on equitable, scalable deployment of POCT, especially where access to traditional laboratory testing is limited.

“When people receive their results straight away and can talk through what they mean with a health professional, it changes how they engage with their health. It helps turn test results into knowledge people can actually use,” said Dr. Kelcie Miller, lead author, College of Medicine and Public Health, Flinders University.

“Point-of-care testing delivers information in a way that is immediate and meaningful. It supports conversations, builds confidence and helps people connect everyday choices with long-term health outcomes,” said Mark Shephard, Matthew Flinders Professor and Founding Director, FHMRI International Center for Point-of-Care Testing, Flinders University.

Related Links
Flinders University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Manual Pipetting Aid
Pipette Controllers macro
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.